In October 2010, the first of a swing of symptoms that lead to my diagnosis began. I was in my final year studying for my degree in Art at the time. I had been working on my dissertation.  I had a slight numbness in my right index finger and thumb, which I thought was caused by excessive use of pens/pencils at the time. Soon that numbness travelled and my hand was numb. I went to a doctor in my college and they thought it was perhaps nerve damage, possibly caused by my sleep position at... more


Dr. Saud A. Sadiq spoke to Joan Hamburg from WABC770 Radio on the research happening at the Tisch MS Research Center of New York and the advances happening in the field of MS. During National MS Awareness Month, Dr. Sadiq explains the importance of finding the cause so that we may find the cure and look toward a future without MS. Click the link below to listen to the full interview - it will also air Saturday, March 12th on the Joan Hamburg Show -  WABC770 Radio during 1:00pm-3:00pm.

... more

The staff at the IMSMP are constantly encouraged and inspired by the accomplishments and activities of our patients. We are proud of what so many of our patients have done in their personal and professional lives.

During National MS Awareness Month, the IMSMP will be highlighting the remarkable things our patients do and the accomplishments they achieve. Whether it's attitude, staying healthy, working, giving back to the community - basically, living life and reaching goals. If you,... more


Dr. Violaine Harris, Senior Research Scientist at Tisch MSRCNY discusses the research involved in our stem cell trial, what HSCT is and how it differs from our stem cell treatment, and ways you can support the important work happening in the lab at Tisch MS Research Center of New York. Click here to view the full video on MSTranslate  


Tisch MSRCNY recently announced the Judith Jaffe Multiple Sclerosis Center at Weill Cornell Medical College will be the other leading MS center to join the Tisch MS Research Center clinical stem cell trial for MS. The Judith Jaffe Center will participate in patient recruitment and data collection.  All costs and expenses related to the study are solely the responsibility of Tisch MSRCNY. We look forward to this collaborative effort!


Congratulations to Dr. Saud A. Sadiq who has been recognized in Castle Connolly's "America's Top Doctors" and "Top Doctors: New York Metro Area for 2016." Dr. Sadiq was recently interviewed on on the promising results from our FDA approved stem cell trial for MS.


The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of books... more


Congratulations to Dr. Sylvester on his selection as a Castle Connolly Top Doctor in the specialty of Neurology for 2016. In addition, Dr. Sylvester has been named a leading Physician of the World. Selected for their experience, forward thinking, and highest quality of care, the Leading Physicians of the World, are the most distinguished and desired medical professionals from every specialty.


Click here for Dr. Andrew Sylvester's full bio


Congratulations to Dr. Williams on his selection as a Castle Connolly Top Doctor in the specialty of Neurology for 2016! The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of books including the "Top Doctors" series, the most popular of which is America's Top Doctors®. The top doctors who are listed in their books and on their website's directory were nominated by their peers in an extensive survey process of... more


Please read and share the interview with Dr. Sadiq about Phase II of the Tisch MS stem cell trial on MS award-winning blog: . The IMSMP would like to thank Marc Stecker for this thoughtful, informative piece.  



Encouraging Results from Phase I Show Reversal of Disability and Repair of Damage Caused by Multiple Sclerosis


New York, NY - January 13, 2016 - Tisch MS Research Center of New York (Tisch MSRCNY) announced today that it will pursue Phase II of its clinical trial, the first stem cell treatment for MS in the United States ever to move to this stage. Following the establishment of safety and tolerability in Phase I with no adverse effects, the Food and Drug... more



Because you deserve only the best in MS healthcare. Experience the difference.

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.